Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.
Description
Enhance your design decisions and seamlessly monitor the entire compound synthesis journey with confidence. Torx serves as an innovative, visually-oriented, web-based platform that motivates chemistry discovery teams to collaborate effectively and accelerate their progress. It features dedicated, independent modules for Design, Make, Test, and Analyze, all working in harmony to provide a comprehensive platform for the discovery cycle. Expedite the design of molecules, easily capture and disseminate knowledge, and manage resources efficiently. The platform promotes collaborative efforts and efficient information sharing for all participants involved in the DMTA cycle. Regardless of whether you label it 'Design-Make-Test-Analyze' or 'Design-Synthesize-Test-Analyze,' all small molecule chemistry teams adhere to a standard process: designing molecules, synthesizing compounds, then testing and assessing the outcomes before embarking on the next cycle; this methodology is a guiding principle for chemistry teams globally. This streamlined approach not only enhances productivity but also fosters a culture of innovation within the team.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
No
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
Yes
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
No
In Person
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Atomwise
Founded
2012
Country
United States
Website
www.atomwise.com
Vendor Details
Company Name
Cresset Group
Founded
2002
Country
United Kingdom
Website
www.torx-software.com
Product Features
Product Features
Chemical
Certificates of Analysis
No
Chemical Process Simulation
No
Computer-Assisted Structure Elucidation (CASE)
No
ISO Management
No
Inventory Management
No
Particle Tracking
No
Reporting & Statistics
No
Samples Tracking
No
Traceability
No
Uncertainty Analysis
No